Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study).
A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses.
Cancers
Koopman, Bart B; Cajiao Garcia, Betzabel N BN; Kuijpers, Chantal C H J CCHJ; Damhuis, Ronald A M RAM; van der Wekken, Anthonie J AJ; Groen, Harry J M HJM; Schuuring, Ed E; Willems, Stefan M SM; van Kempen, Léon C LC
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial.
Ebiomedicine
Hoyer, K K; Hablesreiter, R R; Inoue, Y Y; Yoshida, K K; Briest, F F; Christen, F F; Kakiuchi, N N; Yoshizato, T T; Shiozawa, Y Y; Shiraishi, Y Y; Striefler, J K JK; Bischoff, S S; Lohneis, P P; Putter, H H; Blau, O O; Keilholz, U U; Bullinger, L L; Pelzer, U U; Hummel, M M; Riess, H H; Ogawa, S S; Sinn, M M; Damm, F F
KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes.
Cell Reports
Barbagiovanni, Giulia G; Germain, Pierre-Luc PL; Zech, Michael M; Atashpaz, Sina S; Lo Riso, Pietro P; D'Antonio-Chronowska, Agnieszka A; Tenderini, Erika E; Caiazzo, Massimiliano M; Boesch, Sylvia S; Jech, Robert R; Haslinger, Bernhard B; Broccoli, Vania V; Stewart, Adrian Francis AF; Winkelmann, Juliane J; Testa, Giuseppe G
Publication Date: 2018-10-23
Variant appearance in text: EGFR: 2335G>A; Gly779Ser
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma.
Cellular Oncology (Dordrecht)
Smits, Alexander J J AJ; Kummer, J Alain JA; Hinrichs, John W J JW; Herder, Gerarda J M GJ; Scheidel-Jacobse, Karen C KC; Jiwa, N Mehdi NM; Ruijter, T Emiel G TE; Nooijen, Peet T G A PT; Looijen-Salamon, Monica G MG; Ligtenberg, Marjolijn J L MJ; Thunnissen, Frederik B FB; Heideman, Daniëlle A M DA; de Weger, Roel A RA; Vink, Aryan A
Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.
Bmc Cancer
Pugh, Trevor J TJ; Bebb, Gwyn G; Barclay, Lorena L; Sutcliffe, Margaret M; Fee, John J; Salski, Chris C; O'Connor, Robert R; Ho, Cheryl C; Murray, Nevin N; Melosky, Barbara B; English, John J; Vielkind, Jeurgen J; Horsman, Doug D; Laskin, Janessa J JJ; Marra, Marco A MA